|
Form Serial Number: |
DA20220607E00352
|
1.
Date of relevant event: |
02/06/2022 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
01548 |
4.
Name of listed corporation: |
Genscript Biotech Corporation |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
2,104,298,288 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Liu |
(Other names) |
Zhenyu |
|
|
|
10.
Name of director (Chinese): |
柳振宇 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1201 | The number of shares in which you are interested has reduced because: you completed a sale of the shares | |
|
|
1,668 |
HKD |
|
22.2687 |
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 5,828,866 | 0.28 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 5,827,198 | 0.28 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 22/06/2016 | 21/06/2026 | HKD | 1 | HKD | 1.204 | | | 5,000,000 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 7,762 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 164,361 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 588,016 |
Long position | 4108 | Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 22,626 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Dr. Liu was granted restricted shares underlying (1) 15,524 shares of the Company on 31/5/2021 and among those, 7,762 shares had been vested on 31/05/2022 and the rest will vest on 31/05/2023; (2) 164,361 shares on 10/01/2022 that will vest in five equal installments annually between 11/1/2023 and 11/1/2027; (3) 588,016 shares on 22/03/2022 and the last installment will vest on 22/03/2027 and (4) 22,626 shares on 26 May 2022 that will vest equally on 26/05/2023 and 26/05/2024.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
07/06/2022 (dd/mm/yyyy)
|
|